CD8A and colon adenocarcinoma: Although liothyronine did not inhibit tumor cell proliferation in vitro, it significantly abrogated tumor growth in an in vivo model of colon adenocarcinoma (MC-38) by increasing the levels of CD8+ T cells within the tumor, protection that was lost when either CD4+ or CD8+ T or NK cells were depleted [70].